Although this exact mechanism in breast cancer cells remains to be fully elucidated, the findings support the idea that RKIP modulates the tumor microenvironment by interfering with pro-inflammatory and pro-angiogenic signaling. This evidence concerns the gene PEBP1 and breast cancer.